GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Assertio Holdings Inc (FRA:DPOA) » Definitions » Short-term investments

Assertio Holdings (FRA:DPOA) Short-term investments


View and export this data going back to 2018. Start your Free Trial

What is Assertio Holdings Short-term investments?

Short-term investments only applies to insurance companies.


Assertio Holdings (FRA:DPOA) Business Description

Traded in Other Exchanges
Address
100 South Saunders Road, Suite 300, Lake Forest, IL, USA, 60045
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.